<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Ann Clin Microbiol Antimicrob</journal-id>
      <journal-title>Annals of Clinical Microbiology and Antimicrobials</journal-title>
      <issn pub-type="epub">1476-0711</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">16945159</article-id>
      <article-id pub-id-type="pmc">1586211</article-id>
      <article-id pub-id-type="publisher-id">1476-0711-5-19</article-id>
      <article-id pub-id-type="doi">10.1186/1476-0711-5-19</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Post-ERCP bacteremia caused by <italic>Alcaligenes xylosoxidans </italic>in a patient with pancreas cancer</article-title>
      </title-group>
      <contrib-group>
        <contrib id="A1" corresp="yes" contrib-type="author">
          <name>
            <surname>Yilmaz</surname>
            <given-names>Gurdal</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>gurdalyilmaz53@hotmail.com</email>
        </contrib>
        <contrib id="A2" contrib-type="author">
          <name>
            <surname>Aydin</surname>
            <given-names>Kemalettin</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>kemalettinaydin@yahoo.com</email>
        </contrib>
        <contrib id="A3" contrib-type="author">
          <name>
            <surname>Koksal</surname>
            <given-names>Iftihar</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>iftihar@yahoo.com</email>
        </contrib>
        <contrib id="A4" contrib-type="author">
          <name>
            <surname>Caylan</surname>
            <given-names>Rahmet</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>rahmetcaylan@yahoo.com</email>
        </contrib>
        <contrib id="A5" contrib-type="author">
          <name>
            <surname>Akcay</surname>
            <given-names>Korhan</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>korhanakcay@hotmail.com</email>
        </contrib>
        <contrib id="A6" contrib-type="author">
          <name>
            <surname>Arslan</surname>
            <given-names>Mehmet</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>marslan@meds.ktu.edu.tr</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Department of Infectious Diseases and Clinical Microbiology, Karadeniz Technical University School of Medicine, Trabzon, Turkey</aff>
      <aff id="I2"><label>2</label>Department of Gastroenterology, Karadeniz Technical University School of Medicine, Trabzon, Turkey</aff>
      <pub-date pub-type="collection">
        <year>2006</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>1</day>
        <month>9</month>
        <year>2006</year>
      </pub-date>
      <volume>5</volume>
      <fpage>19</fpage>
      <lpage>19</lpage>
      <ext-link ext-link-type="uri" xlink:href="http://www.ann-clinmicrob.com/content/5/1/19"/>
      <history>
        <date date-type="received">
          <day>29</day>
          <month>5</month>
          <year>2006</year>
        </date>
        <date date-type="accepted">
          <day>1</day>
          <month>9</month>
          <year>2006</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2006 Yilmaz et al; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2006</copyright-year>
        <copyright-holder>Yilmaz et al; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
          <p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
          <!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author>
               Yilmaz
               Gurdal
               
               gurdalyilmaz53@hotmail.com
            </dc:author><dc:title>
            Post-ERCP bacteremia caused by Alcaligenes xylosoxidans in a patient with pancreas cancer
         </dc:title><dc:date>2006</dc:date><dcterms:bibliographicCitation>Annals of Clinical Microbiology and Antimicrobials 5(1): 19-. (2006)</dcterms:bibliographicCitation><dc:identifier type="sici">1476-0711(2006)5:1&#x0003c;19&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1476-0711</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>-->
        </license>
      </permissions>
      <abstract>
        <p><italic>Alcaligenes xylosoxidans </italic>is an aerobic, motile, oxidase and catalase positive, nonfermentative Gram negative bacillus. This bacterium has been isolated from intestine of humans and from various hospital or environmental water sources. <italic>A.xylosoxidans </italic>is both waterborne and results from the poor-hygienic conditions healthcare workers are in. In this case report, the bacteremia which appeared in a patient with pancreas cancer after ERCP was described.</p>
      </abstract>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>Bacteremia is a rare complication of endoscopic retrograde cholangiopancreatography (ERCP) and biliary stents. The rate of post-ERCP cholangitis and sepsis ranges from 0.5% to 3.0% [<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref>].</p>
      <p><italic>Alcaligenes xylosoxidans </italic>is a rare cause of bacteremia. This organism, also known as <italic>Achromobacter xylosoxidans</italic>, is an aerobic, motile, oxidase and catalase positive, nonfermentative Gram negative bacillus. <italic>A.xylosoxidans </italic>is opportunistic and usually affects severely immunocompromised patients such as those with neutropenia and those with a malignant or cardiovascular disease [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B4">4</xref>]. This microorganism has been isolated from blood, cerebrospinal fluid, stool, urine, sputum, peritoneal fluid, skin, ear discharge, wounds, abscesses, bone, joints, endocardium and central venous catheters [<xref ref-type="bibr" rid="B3">3</xref>-<xref ref-type="bibr" rid="B8">8</xref>].</p>
      <p>In the present report is described a case with bacteremia due to <italic>A.xylosoxidans </italic>post-ERCP in patient of pancreas cancer.</p>
    </sec>
    <sec>
      <title>Case report</title>
      <p>A 70-year-old man was admitted to our hospital with a 10-day history of jaundice and abdominal pain. The patient is known to have suffered from pancreas cancer for three months and he was received second cycle of chemotherapy before one month. His vitality signs were: blood pressure was 110/70 mmHg, body temperature 36.3&#xB0;C and pulse rate 68/min. His peripheral white blood cell count was 6.4 &#xD7; 10<sup>9</sup>/L, erythrocyte sedimentation rate was 72 mm/h and C-reactive protein was 4.6 mg/dL. Four days later, the stent was placed into the biliary tract with ERCP. One day later, the patient was lethargic. His vitality signs were: blood pressure was 90/50 mmHg, body temperature 39.7&#xB0;C and pulse rate 112/min. His peripheral white blood cell count was 14.1 &#xD7; 10<sup>9</sup>/L with 86% neutrophils and 8% lymphocytes. His erythrocyte sedimentation rate was 80 mm/h and C-reactive protein was 11.2 mg/dL. Blood and urine specimens were taken for microbiologycal analysis. We started to administer empirical treatment with ceftriaxone (1000 mg per 12 h; IV) to the patient. In blood culture (Bactec 9240; Becton Dickinson, Sparks, Md.), Gram negative bacillus was found to have reproduced. This microorganism identified with the help of Phoenix system (Becton Dickinson, Sparks, Md.) and biochemical tests. It was called as <italic>A.xylosoxidans</italic>. <italic>A.xylosoxidans </italic>was distinguished from other Alcaligenes species by acidification of oxidative-fermentative (OF) glucose and xylose. Key characteristics of <italic>A.xylosoxidans </italic>are shown in Table <xref ref-type="table" rid="T1">1</xref>.</p>
      <table-wrap position="float" id="T1">
        <label>Table 1</label>
        <caption>
          <p>Key characteristics of <italic>A.xylosoxidans</italic></p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <td align="left">
                <bold>Tests</bold>
              </td>
              <td align="center">
                <bold>Results</bold>
              </td>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left">Oxidase</td>
              <td align="center">+</td>
            </tr>
            <tr>
              <td align="left">Catalase</td>
              <td align="center">+</td>
            </tr>
            <tr>
              <td align="left">OF xylose</td>
              <td align="center">Acid reaction</td>
            </tr>
            <tr>
              <td align="left">OF glucose</td>
              <td align="center">Acid reaction</td>
            </tr>
            <tr>
              <td align="left">Arginine</td>
              <td align="center">-</td>
            </tr>
            <tr>
              <td align="left">Citrate</td>
              <td align="center">+</td>
            </tr>
            <tr>
              <td align="left">Ketoglutaric acid</td>
              <td align="center">+</td>
            </tr>
            <tr>
              <td align="left">Gamma glutamil</td>
              <td align="center">+</td>
            </tr>
            <tr>
              <td align="left">NO<sub>3 </sub>to NO<sub>2</sub></td>
              <td align="center">+</td>
            </tr>
            <tr>
              <td align="left">Acetamide</td>
              <td align="center">+</td>
            </tr>
            <tr>
              <td align="left">Lysine</td>
              <td align="center">-</td>
            </tr>
            <tr>
              <td align="left">Mannitol</td>
              <td align="center">-</td>
            </tr>
            <tr>
              <td align="left">Urease</td>
              <td align="center">-</td>
            </tr>
            <tr>
              <td align="left">Motility</td>
              <td align="center">+</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p>The urine culture was sterile. Three days later, the initial treatment was modified to ciprofloxacine (200 mg per 12 h; IV) according to antimicrobial susceptibility test. In-vitro susceptibility data are shown in Table <xref ref-type="table" rid="T2">2</xref>. This isolate is an ESBL producer. Five days later, the clinical condition of the patient improved. He was discharged in a good clinical condition after 15 days.</p>
      <table-wrap position="float" id="T2">
        <label>Table 2</label>
        <caption>
          <p>In-vitro susceptibility profile of <italic>A.xylosoxidans</italic></p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <td align="left">
                <bold>Antimicrobial agent</bold>
              </td>
              <td align="left">
                <bold>Susceptibility</bold>
              </td>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td align="left">Amikacin</td>
              <td align="left">Resistant</td>
            </tr>
            <tr>
              <td align="left">Cefoperazone/sulbactam</td>
              <td align="left">Sensitive</td>
            </tr>
            <tr>
              <td align="left">Cefotaxime</td>
              <td align="left">Resistant</td>
            </tr>
            <tr>
              <td align="left">Ceftazidime</td>
              <td align="left">Resistant</td>
            </tr>
            <tr>
              <td align="left">Ceftriaxone</td>
              <td align="left">Resistant</td>
            </tr>
            <tr>
              <td align="left">Ciprofloxacin</td>
              <td align="left">Sensitive</td>
            </tr>
            <tr>
              <td align="left">Imipenem</td>
              <td align="left">Sensitive</td>
            </tr>
            <tr>
              <td align="left">Piperacillin/tazobactam</td>
              <td align="left">Sensitive</td>
            </tr>
            <tr>
              <td align="left">Tobramycin</td>
              <td align="left">Resistant</td>
            </tr>
            <tr>
              <td align="left">Trimethoprim/sulfametoxazole</td>
              <td align="left">Sensitive</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
    </sec>
    <sec>
      <title>Discussion</title>
      <p>Obstruction of the bile duct by stones or tumor can facilitate bacterial colonization; subsequent instrumentation has resulted in bacteremia rates mean 18.0%. [<xref ref-type="bibr" rid="B9">9</xref>,<xref ref-type="bibr" rid="B10">10</xref>]. The highest bacteremia rates are seen in therapeutic ERCP. In purely diagnostic ERCP, the bacteremic rate is lower at 8% [<xref ref-type="bibr" rid="B10">10</xref>,<xref ref-type="bibr" rid="B11">11</xref>]. The microorganism most responsible for post-ERCP bacteremia is <italic>Escherichia coli </italic>[<xref ref-type="bibr" rid="B9">9</xref>]
. <italic>A.xylosoxidans </italic>is a rare but important cause of bacteremia in immunocompromised patients. The gastrointestinal tract has been suggested as a source for <italic>A.xylosoxidans </italic>bacteremia in patients with cancer [<xref ref-type="bibr" rid="B12">12</xref>]. Our case report is the first one associated with <italic>A.xylosoxidans </italic>that causes post-ERCP bacteremia.</p>
      <p><italic>A.xylosoxidans </italic>has been isolated from intestine of humans and from various hospital or environmental water sources [<xref ref-type="bibr" rid="B13">13</xref>]. The natural sources of <italic>A.xylosoxidans </italic>infections are well water, tap water, swimming pools, and moist soil [<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B15">15</xref>]. <italic>A.xylosoxidans </italic>causing nosocomial infections is waterborne (disinfectant solutions, intravenous fluids, dialysis solutions) and results from the fact that healthcare workers do not use gloves [<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B16">16</xref>]. In our case, peripheral factors wereanalysed as a source of infection but any environmental contamination couldn't be indicated. Thatthe patient had symptoms of infection one day after ERCP made us think that the infection was from the intestines.</p>
      <p><italic>A.xylosoxidans </italic>is a weakly virulent microorganism. In general, there is an underlying dissease in patients. <italic>A.xylosoxidans </italic>have been reported in patients with cancer, neutropenia, bone marrow or liver transplant, renal failure, cystic fibrosis, HIV infection, IgM deficiency, neonates [<xref ref-type="bibr" rid="B4">4</xref>-<xref ref-type="bibr" rid="B6">6</xref>,<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B17">17</xref>]
.</p>
      <p>This report showed that <italic>A.xylosoxidans </italic>was sensitive to cefoperazone/sulbactam, ciprofloxacin, imipenem, piperacillin/tazobactam and trimethoprim/sulfametoxazole and resistant to the third generation cephalosporins with the exception of the cefoperazone/sulbactam, amikacin and tobramycin. In previous studies, it was reported that <italic>A.xylosoxidans </italic>was resistant to most of the antimicrobial agents [<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B18">18</xref>].</p>
      <p>In summary, the post-ERCP bacteremia caused by <italic>A.xylosoxidans </italic>was presented in a 70-year-old man with pancreas cancer. The case report may help to redefine the role of <italic>A.xylosoxidans </italic>in post ERCP infections. The association of <italic>A.xylosoxidans </italic>with bacteremia further extends the clinical spectrum of this rare pathogen. This unusual case highlights that an effective antimicrobial therapy based on an immediate microbiologycal analysis may be life-saving in patients presenting a severe complication of ERCP.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Loperfido</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Angelini</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Benedetti</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Chilovi</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Costan</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>De Berardinis</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>De Bernardin</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ederle</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Fina</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Fratton</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study</article-title>
          <source>Gastrointest Endosc</source>
          <year>1998</year>
          <volume>48</volume>
          <fpage>1</fpage>
          <lpage>10</lpage>
          <pub-id pub-id-type="pmid">9684657</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0016-5107(98)70121-X</pub-id>
        </citation>
      </ref>
      <ref id="B2">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Masci</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Toti</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Mariani</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Curioni</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Lomazzi</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Dinelli</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Minoli</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Crosta</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Comin</surname>
              <given-names>U</given-names>
            </name>
            <name>
              <surname>Fertitta</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Prada</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Passoni</surname>
              <given-names>GR</given-names>
            </name>
            <name>
              <surname>Testoni</surname>
              <given-names>PA</given-names>
            </name>
          </person-group>
          <article-title>Complications of diagnostic and therapeutic ERCP: a prospective multicenter study</article-title>
          <source>Am J Gastroenterol</source>
          <year>2001</year>
          <volume>96</volume>
          <fpage>417</fpage>
          <lpage>423</lpage>
          <pub-id pub-id-type="pmid">11232684</pub-id>
          <pub-id pub-id-type="doi">10.1111/j.1572-0241.2001.03594.x</pub-id>
        </citation>
      </ref>
      <ref id="B3">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Duggan</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Goldstein</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Chenoweth</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Kauffman</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Bradley</surname>
              <given-names>SF</given-names>
            </name>
          </person-group>
          <article-title>Achromobacter xylosoxidans bacteremia: report of four cases and review of the literature</article-title>
          <source>Clin Infect Dis</source>
          <year>1996</year>
          <volume>23</volume>
          <fpage>569</fpage>
          <lpage>576</lpage>
          <pub-id pub-id-type="pmid">8879782</pub-id>
        </citation>
      </ref>
      <ref id="B4">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aisenberg</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Rolston</surname>
              <given-names>KV</given-names>
            </name>
            <name>
              <surname>Safdar</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Bacteremia caused by Achromobacter and Alcaligenes species in 46 patients with cancer (1989&#x2013;2003)</article-title>
          <source>Cancer</source>
          <year>2004</year>
          <volume>101</volume>
          <fpage>2134</fpage>
          <lpage>2140</lpage>
          <pub-id pub-id-type="pmid">15389476</pub-id>
          <pub-id pub-id-type="doi">10.1002/cncr.20604</pub-id>
        </citation>
      </ref>
      <ref id="B5">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gradon</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Mayrer</surname>
              <given-names>AR</given-names>
            </name>
            <name>
              <surname>Hayes</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Pulmonary abscess associated with Alcaligenes xylosoxidans in a patient with AIDS</article-title>
          <source>Clin Infect Dis</source>
          <year>1993</year>
          <volume>17</volume>
          <fpage>1071</fpage>
          <lpage>1072</lpage>
          <pub-id pub-id-type="pmid">8110940</pub-id>
        </citation>
      </ref>
      <ref id="B6">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ahn</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>NH</given-names>
            </name>
            <name>
              <surname>Shin</surname>
              <given-names>DH</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>OY</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Jeong</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Cho</surname>
              <given-names>JG</given-names>
            </name>
            <name>
              <surname>Park</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Kang</surname>
              <given-names>JC</given-names>
            </name>
          </person-group>
          <article-title>Pacemaker lead endocarditis caused by Achromobacter xylosoxidans</article-title>
          <source>J Korean Med Sci</source>
          <year>2004</year>
          <volume>19</volume>
          <fpage>291</fpage>
          <lpage>293</lpage>
          <pub-id pub-id-type="pmid">15082906</pub-id>
        </citation>
      </ref>
      <ref id="B7">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weissgold</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Kirkpatrick</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Iverson</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Acute postoperative Alcaligenes xylosoxidans endophthalmitis</article-title>
          <source>Retina</source>
          <year>2003</year>
          <volume>23</volume>
          <fpage>578</fpage>
          <lpage>580</lpage>
          <pub-id pub-id-type="pmid">12972784</pub-id>
          <pub-id pub-id-type="doi">10.1097/00006982-200308000-00032</pub-id>
        </citation>
      </ref>
      <ref id="B8">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ramos</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Domine</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ponte</surname>
              <given-names>MC</given-names>
            </name>
            <name>
              <surname>Soriano</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Bacteremia caused by Alcaligenes (Achromobacter) xylosoxidans. Description of 3 cases and review of the literature</article-title>
          <source>Enferm InfeccMicrobiol Clin</source>
          <year>1996</year>
          <volume>14</volume>
          <fpage>436</fpage>
          <lpage>440</lpage>
        </citation>
      </ref>
      <ref id="B9">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Leung</surname>
              <given-names>JW</given-names>
            </name>
            <name>
              <surname>Ling</surname>
              <given-names>TK</given-names>
            </name>
            <name>
              <surname>Chan</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Cheung</surname>
              <given-names>SW</given-names>
            </name>
            <name>
              <surname>Lai</surname>
              <given-names>CW</given-names>
            </name>
            <name>
              <surname>Sung</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Chung</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Cheng</surname>
              <given-names>AF</given-names>
            </name>
          </person-group>
          <article-title>Antibiotics, biliary sepsis, and bile duct stones</article-title>
          <source>Gastrointest Endosc</source>
          <year>1994</year>
          <volume>40</volume>
          <fpage>716</fpage>
          <lpage>721</lpage>
          <pub-id pub-id-type="pmid">7859970</pub-id>
        </citation>
      </ref>
      <ref id="B10">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kullman</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Borch</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Lindstrom</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Ansehn</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Ihse</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Anderberg</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Bacteremia following diagnostic and therapeutic ERCP</article-title>
          <source>Gastrointest Endosc</source>
          <year>1992</year>
          <volume>38</volume>
          <fpage>444</fpage>
          <lpage>449</lpage>
          <pub-id pub-id-type="pmid">1511819</pub-id>
        </citation>
      </ref>
      <ref id="B11">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mollison</surname>
              <given-names>LC</given-names>
            </name>
            <name>
              <surname>Desmond</surname>
              <given-names>PV</given-names>
            </name>
            <name>
              <surname>Stockman</surname>
              <given-names>KA</given-names>
            </name>
            <name>
              <surname>Andrew</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Watson</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Shaw</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Breen</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>A prospective study of septic complications of endoscopic retrograde cholangiopancreatography</article-title>
          <source>J Gastroenterol Hepatol</source>
          <year>1994</year>
          <volume>9</volume>
          <fpage>55</fpage>
          <lpage>59</lpage>
          <pub-id pub-id-type="pmid">8155867</pub-id>
        </citation>
      </ref>
      <ref id="B12">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Legrand</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Anaissie</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Bacteremia due to Achromobacter xylosoxidans in patients with cancer</article-title>
          <source>Clin Infect Dis</source>
          <year>1992</year>
          <volume>14</volume>
          <fpage>479</fpage>
          <lpage>484</lpage>
          <pub-id pub-id-type="pmid">1554834</pub-id>
        </citation>
      </ref>
      <ref id="B13">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vu-Thien</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Darbord</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Moissenet</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Dulot</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Dufourcq</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Marsol</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Garbarg-Chenon</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Investigation of an outbreak of wound infections due to Alcaligenes xylosoxidans transmitted by chlorhexidine in a burns unit</article-title>
          <source>Eur J Clin Microbiol Infect Dis</source>
          <year>1998</year>
          <volume>17</volume>
          <fpage>724</fpage>
          <lpage>726</lpage>
          <pub-id pub-id-type="pmid">9865987</pub-id>
          <pub-id pub-id-type="doi">10.1007/s100960050168</pub-id>
        </citation>
      </ref>
      <ref id="B14">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spear</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Fuhrer</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kirby</surname>
              <given-names>BD</given-names>
            </name>
          </person-group>
          <article-title>Achromobacter xylosoxidans (Alcaligenes xylosoxidans subsp. xylosoxidans) bacteremia associated with a well-water source: case report and review of the literature</article-title>
          <source>J Clin Microbiol</source>
          <year>1988</year>
          <volume>26</volume>
          <fpage>598</fpage>
          <lpage>599</lpage>
          <pub-id pub-id-type="pmid">3281982</pub-id>
        </citation>
      </ref>
      <ref id="B15">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Reverdy</surname>
              <given-names>ME</given-names>
            </name>
            <name>
              <surname>Freney</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Fleurette</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Coulet</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Surgot</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Marmet</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Ploton</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Nosocomial colonization and infection by Achromobacter xylosoxidans</article-title>
          <source>J Clin Microbiol</source>
          <year>1984</year>
          <volume>19</volume>
          <fpage>140</fpage>
          <lpage>143</lpage>
          <pub-id pub-id-type="pmid">6699141</pub-id>
        </citation>
      </ref>
      <ref id="B16">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gomez-Cerezo</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Suarez</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Rios</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Pena</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Garcia de Miguel</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>de Jose</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Monteagudo</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Linares</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Barbado-Cano</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Vazquez</surname>
              <given-names>JJ</given-names>
            </name>
          </person-group>
          <article-title>Achromobacter xylosoxidans bacteremia: a 10-year analysis of 54 cases</article-title>
          <source>Eur J Clin Microbiol Infect Dis</source>
          <year>2003</year>
          <volume>22</volume>
          <fpage>360</fpage>
          <lpage>363</lpage>
          <pub-id pub-id-type="pmid">12750959</pub-id>
          <pub-id pub-id-type="doi">10.1007/s10096-003-0925-3</pub-id>
        </citation>
      </ref>
      <ref id="B17">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Weitkamp</surname>
              <given-names>JH</given-names>
            </name>
            <name>
              <surname>Tang</surname>
              <given-names>YW</given-names>
            </name>
            <name>
              <surname>Haas</surname>
              <given-names>DW</given-names>
            </name>
            <name>
              <surname>Midha</surname>
              <given-names>NK</given-names>
            </name>
            <name>
              <surname>Crowe</surname>
              <given-names>JE</given-names>
              <suffix>Jr</suffix>
            </name>
          </person-group>
          <article-title>Recurrent Achromobacter xylosoxidans bacteremia associated with persistent lymph node infection in a patient with hyper-immunoglobulin M syndrome</article-title>
          <source>Clin Infect Dis</source>
          <year>2000</year>
          <volume>31</volume>
          <fpage>1183</fpage>
          <lpage>1187</lpage>
          <pub-id pub-id-type="pmid">11073750</pub-id>
          <pub-id pub-id-type="doi">10.1086/317461</pub-id>
        </citation>
      </ref>
      <ref id="B18">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mandell</surname>
              <given-names>WF</given-names>
            </name>
            <name>
              <surname>Garvey</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Neu</surname>
              <given-names>HC</given-names>
            </name>
          </person-group>
          <article-title>Achromobacter xylosoxidans bacteremia</article-title>
          <source>Rev Infect Dis</source>
          <year>1987</year>
          <volume>9</volume>
          <fpage>1001</fpage>
          <lpage>1005</lpage>
          <pub-id pub-id-type="pmid">3317727</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
